Jacques Gonella, Director at ANTARES PHARMA, INC. (ATRS), sold 413,224 shares at $2.70 ($1.1M) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market sale of $1.1M ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.70 | 56,612 | $153K | 14.1% |
| 2 | $2.70 | 56,612 | $153K | 14.1% |
| 3 | $2.65 | 100,000 | $265K | 24.5% |
| 4 | $2.55 | 100,000 | $255K | 23.6% |
| 5 | $2.55 | 100,000 | $255K | 23.6% |
| Total | $2.62 avg | 413,224 |
| $1.1M |
| 100% |
| Filing → |
| ATRS | SELL | 2018-08-15 | $306K | — | Filing → |
| ATRS | SELL | 2018-08-10 | $1.5M | — | Filing → |
| ATRS | SELL | 2018-06-20 | $2K | — | Filing → |